<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.1//EN" "ep-patent-document-v1-1.dtd">
<ep-patent-document id="EP01990437B8W1" file="EP01990437W1B8.xml" lang="en" country="EP" doc-number="1349839" kind="B8" correction-code="W1" date-publ="20050622" status="c" dtd-version="ep-patent-document-v1-1">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTR............................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>DIM350 (Ver 2.1 Jan 2001)
 2999001/0</B007EP><B070EP>The file contains technical information submitted after the application was filed and not included in this specification</B070EP></eptags></B000><B100><B110>1349839</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20050622</date></B140><B150><B151>W1</B151><B153>84</B153><B155><B1551>DE</B1551><B1552>Bibliographie</B1552><B1551>EN</B1551><B1552>Bibliography</B1552><B1551>FR</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>01990437.4</B210><B220><date>20011126</date></B220><B240><B241><date>20030704</date></B241></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>00126615</B310><B320><date>20001204</date></B320><B330><ctry>EP</ctry></B330></B300><B400><B405><date>20050622</date><bnum>200525</bnum></B405><B430><date>20031008</date><bnum>200341</bnum></B430><B450><date>20050209</date><bnum>200506</bnum></B450><B452EP><date>20040802</date></B452EP><B480><date>20050622</date><bnum>200525</bnum></B480></B400><B500><B510><B516>7</B516><B511> 7C 07D 233/90   A</B511><B512> 7A 61K  31/4164 B</B512><B512> 7C 07D 413/04   B</B512><B512> 7A 61P  25/28   B</B512></B510><B540><B541>de</B541><B542>PHENYLETHENYL- ODER PHENYLETHINYLDERIVATE ALS GLUTAMATREZEPTORANTAGONISTEN</B542><B541>en</B541><B542>PHENYLETHENYL OR PHENYLETHINYL DERIVATIVES AS GLUTAMATE RECEPTOR ANTAGONISTS</B542><B541>fr</B541><B542>DERIVES PHENYLETHENYLE OU PHENYLETHINYLE SERVANT D'ANTAGONISTES DE RECEPTEUR DE GLUTAMATE</B542></B540><B560><B561><text>WO-A-01/16121</text></B561><B561><text>WO-A-99/02497</text></B561><B561><text>WO-A-99/08678</text></B561><B561><text>DE-A- 2 035 905</text></B561><B562><text>A. SHAFIEE ET AL.: "Synthesis of 2-(2-arylethyl)-1-methylimidazoles" J. HETEROCYCL. CHEM., vol. 33, no. 3, 1996, pages 671-673, XP001069539</text></B562><B562><text>T. SAKAMOTO ET AL.: "Palladium-catalyzed reactions of terminal acetylenes and olefins with halo-1,3-azoles" CHEM. PHARM. BULL., vol. 35, no. 2, 1987, pages 823-828, XP001068936 cited in the application</text></B562><B562><text>A. SHAFIEE ET AL.: "Synthesis of 2-(2-arylethyl)imidazoles" J. HETEROCYCLIC CHEM., vol. 35, no. 3, 1998, pages 607-610, XP001069546</text></B562><B562><text>DATABASE CROSSFIRE BEILSTEIN [Online] Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, DE; Database accession no. 8615795 XP002197389 &amp; IVANOVA ET AL.: CHEM. HETEROCYCL. COMP. (ENGL. TRANSL.), vol. 36, no. 2, 2000, pages 262-264,</text></B562><B562><text>DATABASE CROSSFIRE BEILSTEIN [Online] Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, DE; Database accession no. 141661 XP002197390 &amp; WADSWORTH: J. CHEM. SOC., vol. 57, 1890, page 11</text></B562><B562><text>DATABASE CROSSFIRE BEILSTEIN [Online] Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, DE; Database accession no. 3960 XP002197391 &amp; CORNFORTH; COOKSON: J. CHEM. SOC., - 1952 pages 1085-1087,</text></B562><B562><text>CHEMICAL ABSTRACTS, vol. 78, no. 3, 1973 Columbus, Ohio, US; abstract no. 11433e, page 10; XP002197388 &amp; W. ROSS: "Antiparasitic nitroimidazoles" J. MED. CHEM., vol. 15, no. 10, 1972, pages 1035-40,</text></B562><B562><text>MILLER R D ET AL: "SUBSTITUTED AZOLE DERIVATIVES AS NONLINEAR OPTICAL CHROMOPHORES" CHEMISTRY OF MATERIALS, AMERICAN CHEMICAL SOCIETY, WASHINGTON, US, vol. 6, no. 7, 1994, pages 1023-1032, XP002028006 ISSN: 0897-4756 cited in the application</text></B562></B560></B500><B700><B720><B721><snm>MUTEL, Vincent</snm><adr><str>6, Rue des Grands Champs</str><city>F-68350 Brunstatt</city><ctry>FR</ctry></adr></B721><B721><snm>PETERS, Jens-Uwe</snm><adr><str>Bertlingen 14</str><city>79639 Grenzach-Wyhlen</city><ctry>DE</ctry></adr></B721><B721><snm>WICHMANN, Juergen</snm><adr><str>Im Wolfischbuehl 32</str><city>79585 Steinen</city><ctry>DE</ctry></adr></B721></B720><B730><B731><snm>F. Hoffmann-La Roche AG</snm><iid>01107064</iid><irf>Case 20772</irf><syn>Hoffmann-La Roche AG, F.</syn><syn>Roche AG, F. Hoffmann-La</syn><adr><str>Grenzacherstrasse 124</str><city>4070 Basel</city><ctry>CH</ctry></adr></B731></B730><B740><B741><snm>Heiroth, Ulrike Hildegard</snm><sfx>et al</sfx><iid>00092581</iid><adr><str>124 Grenzacherstrasse</str><city>4070 Basle</city><ctry>CH</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry><ctry>TR</ctry></B840><B844EP><B845EP><ctry>LT</ctry><date>20030704</date></B845EP><B845EP><ctry>LV</ctry><date>20030704</date></B845EP><B845EP><ctry>MK</ctry><date>20030704</date></B845EP><B845EP><ctry>RO</ctry><date>20030704</date></B845EP><B845EP><ctry>SI</ctry><date>20030704</date></B845EP></B844EP><B860><B861><dnum><anum>EP2001013714</anum></dnum><date>20011126</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2002046166</pnum></dnum><date>20020613</date><bnum>200224</bnum></B871></B870></B800></SDOBI>
</ep-patent-document>
